Part II: Clinical AI Across Medical Specialties: What Trials Reveal About Diagnostic Accuracy, Patient Outcomes, Enterprise Adoption, Specialist Work, and the Commercial Limits of Autonomous Care

Thoughts on Healthcare Markets & Technology Podcast

0:00

-9:59

Paid episode

The full episode is only available to paid subscribers of Thoughts on Healthcare Markets & Technology

Part II: Clinical AI Across Medical Specialties: What Trials Reveal About Diagnostic Accuracy, Patient Outcomes, Enterprise Adoption, Specialist Work, and the Commercial Limits of Autonomous Care

Nov 02, 2026

∙ Paid

Breast screening AI in a 105,000-woman trial raised cancer detection from 5 to 6.4 per thousand screened. Reading workload fell 44%. That’s real. But it’s not a 44% staffing cut.

Cardiology AI found more reduced ejection fraction. Gastroenterology AI found more polyps. Ophthalmology AI got screening to 100% completion vs 22% after referral. More detectio…

Continue reading this post for free, courtesy of Trey’s Thoughts on Healthcare.

Or purchase a paid subscription.